{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:06:50Z","timestamp":1792832810393,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ligue Europ\u00e9enne contre la maladie d\u2019Alzheimer"},{"name":"fondation Georges Pompidou"},{"name":"Investissements d'avenir","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}]}],"content-domain":{"domain":["neurobiologyofaging.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.neurobiolaging.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:13:09Z","timestamp":1426695189000},"page":"2043-2052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Acute amnestic encephalopathy in amyloid-\u03b2 oligomer\u2013injected mice is due to their widespread diffusion in\u00a0vivo"],"prefix":"10.1016","volume":"36","author":[{"given":"St\u00e9phane","family":"Epelbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsen","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale N.","family":"Lacor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Chaurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Duplus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Brugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Duyckaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Delatour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","article-title":"Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology","volume":"45","author":"Abbott","year":"2004","journal-title":"Neurochem. Int."},{"issue":"Pt 4","key":"10.1016\/j.neurobiolaging.2015.03.005_bib2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/brain\/awu035","article-title":"Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline","volume":"137","author":"Amieva","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib4","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u00df oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib8","first-page":"153218","article-title":"Chronic treatment with a promnesiant GABA-a \u03b15-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down syndrome mouse model","volume":"2011","author":"Braudeau","year":"2011","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib9","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1523\/JNEUROSCI.5901-11.2012","article-title":"Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-\u00df1-42 oligomers are revealed in\u00a0vivo by using a novel animal model","volume":"32","author":"Brouillette","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","article-title":"Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology","volume":"34","author":"Carare","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib11","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1016\/j.jprot.2012.04.005","article-title":"Imaging mass spectrometry of thin tissue sections: a decade of collective efforts","volume":"75","author":"Chaurand","year":"2012","journal-title":"J.\u00a0Proteomics"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jms.1180","article-title":"Instrument design and characterization for high resolution MALDI-MS imaging of tissue sections","volume":"42","author":"Chaurand","year":"2007","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib13","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","article-title":"Self-assembly of Abeta(1-42) into globular neurotoxins","volume":"42","author":"Chromy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nmeth1094","article-title":"MALDI imaging mass spectrometry: molecular snapshots of biochemical systems","volume":"4","author":"Cornett","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nmeth.2075","article-title":"Icy: an open bioimage informatics platform for extended reproducible research","volume":"9","author":"de Chaumont","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib18","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.neuropsychologia.2007.11.030","article-title":"Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies","volume":"46","author":"Dickerson","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuroimage.2010.02.074","article-title":"Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"51","author":"Dubois","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/bpa.12049","article-title":"From soluble abeta to progressive abeta aggregation: could prion-like templated misfolding play a role?","volume":"23","author":"Eisele","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/cn400183w","article-title":"Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's ss-amyloid peptides","volume":"5","author":"Fantini","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib24","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1523\/JNEUROSCI.0482-13.2013","article-title":"Memantine rescues transient cognitive impairment caused by high-molecular-weight abeta oligomers but not the persistent impairment induced by low-molecular-weight oligomers","volume":"33","author":"Figueiredo","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib25","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1096\/fj.09-150359","article-title":"High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients","volume":"24","author":"Fukumoto","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0197-4580(92)90057-5","article-title":"Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain","volume":"13","author":"Games","year":"1992","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib27","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1523\/JNEUROSCI.4182-09.2010","article-title":"Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease","volume":"30","author":"Garcia","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib28","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/alzrt272","article-title":"Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics","volume":"6","author":"Goure","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","article-title":"Soluble abeta oligomers are rapidly sequestered from brain ISF in\u00a0vivo and bind GM1 ganglioside on cellular membranes","volume":"82","author":"Hong","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib34","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0197-0186(02)00050-5","article-title":"Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets","volume":"41","author":"Klein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/138920207783769530","article-title":"Advances on the understanding of the origins of synaptic pathology in AD","volume":"8","author":"Lacor","year":"2007","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib39","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib41","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","article-title":"Monoclonal antibodies that target pathological assemblies of Abeta","volume":"100","author":"Lambert","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib43","doi-asserted-by":"crossref","first-page":"950783","DOI":"10.1155\/2013\/950783","article-title":"Breaking the code of amyloid- oligomers","volume":"2013","author":"Lesne","year":"2013","journal-title":"Int. J. Cell Biol."},{"issue":"Pt 5","key":"10.1016\/j.neurobiolaging.2015.03.005_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-beta oligomers in ageing and Alzheimer's disease","volume":"136","author":"Lesne","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.emboj.7601953","article-title":"Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice","volume":"27","author":"Martins","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2010-101263","article-title":"Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice","volume":"23","author":"Moon","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib48","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1073\/pnas.92.21.9697","article-title":"Spatial learning with a minislab in the dorsal hippocampus","volume":"92","author":"Moser","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib49","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0031-3203(01)00127-3","article-title":"Extraction of spots in biological images using multiscale products","volume":"35","author":"Olivo-Marin","year":"2002","journal-title":"Pattern Recognition"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib51","series-title":"The Mouse Brain in Stereotaxic Coordinates: Compact Second Edition","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-2012-112192","article-title":"Intrahippocampal administration of amyloid-beta(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism","volume":"30","author":"Pearson-Leary","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid \u00df oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib57","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In\u00a0vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuint.2007.04.007","article-title":"Extrasynaptic transmission and the diffusion parameters of the extracellular space","volume":"52","author":"Sykova","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib59","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1096\/fj.13-229666","article-title":"Brain interstitial oligomeric amyloid beta increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease","volume":"27","author":"Takeda","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib60","series-title":"The Use of Immediate Early Genes as Mapping Tools for Neuronal Activation: Concepts and Methods","first-page":"1","author":"Terleph","year":"2006"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib61","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"Pt 2","key":"10.1016\/j.neurobiolaging.2015.03.005_bib62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10571-011-9691-4","article-title":"A\u00df oligomer-induced synapse degeneration in Alzheimer's disease","volume":"31","author":"Wilcox","year":"2011","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib65","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib66","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.neurobiolaging.2007.03.005","article-title":"N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis","volume":"29","author":"Youssef","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.03.005_bib67","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines","volume":"30","author":"Zempel","year":"2010","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015001669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015001669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T03:33:36Z","timestamp":1566444816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015001669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0197458015001669"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.03.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute amnestic encephalopathy in amyloid-\u03b2 oligomer\u2013injected mice is due to their widespread diffusion in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}